Solid Cancer Therapy
Studies from Pennsylvania State University, Department of Hematology-Oncology provide new data on solid cancer therapy
Published in Clinical Oncology Week, July 21st, 2008
Current study results from the report, 'Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid,' have been published. According to a study from the United States, "For patients with bone metastases, high N-telopeptide of type I collagen (NTX) levels correlate with increased risks of skeletal-related events and death. However, the relation between NTX decreases and clinical benefits is unclear."
"Correlations between NTX normalization during treatment and clinical outcome were retrospectively analyzed in 3 large, phase 3 trials. Urinary NTX levels were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- American Association for Cancer Research
Prostate cancer vaccines more effective with hormone therapy - BioMed Central
Guidelines for care of elderly patients ignored - Broad Institute of Mit and Harvard
Researchers unveil near-complete protein catalog for mitochondria - JAMA and Archives Journals
Androgen deprivation therapy for localized prostate cancer not associated with improved survival - Journal of the National Cancer Institute
Higher education associated with greater gains in mortality reduction from common cancers - Research
Bacterial peptide provides new insight into common tumor suppressor - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
